Nirsevimab: The Hidden Costs

• 2024

  Sign in to bookmark this resource.

  Sign in
• Samantha Neumann; Brian Alverson
PMID: 38721666DOI: https://dx.doi.org/10.1542/hpeds.2024-007739

---

Access Resources

• Journal ArticleEN

About

This brief article describes how nirsevimab is effective but expensive and raises concerns about its cost-effectiveness. The drug's immunity fades quickly, protecting infants for only one RSV season. There are worries that widespread use might lead to more hospitalizations in older children and resistant virus strains. The article calls for more studies on the long-term effects of using nirsevimab before continuing its broad rollout in pediatric care programs like Vaccines for Children (VFC).

---

Tags

Focus Area: Infectious Disease

Audiences: Emergency Managers; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Child; Cost-Benefit Analysis; Infant; Pediatrics; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Drug Costs; Immunization Programs; Respiratory Syncytial Virus, Human; Antibodies, Monoclonal, Humanized

Institutions: Nemours Children's Health; Thomas Jefferson University

---

More like this

National Preparedness Survey of Pediatric Intensive Care Units with Simulation Centers During the Coronavirus Pandemic 2020 · Indiana University, Yale School of Medicine, Yale University, Florida Atlantic University, Wayne State University, Thomas Jefferson University, Riley Children's Health The Role of the Pediatric Orthopaedic Surgeon in Disaster Response 2014 · Pennsylvania State University, Nemours Children's Health Mental Health Impact of Pandemics and Other Public Health Emergencies in Children 2024 · Children's Hospital Los Angeles, University of Southern California

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---